Intellia Therapeutics, Inc. NTLA
10.97 USD -1.14 (-9.41%)
Nov 10, 2026, 11:47 AM EST
10.96 Day range 11.87
7.95 52-week range 18.48
- YTD
- +22.02%
- 1 year
- +12.74%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 67.67M | 57.88M | 36.27M | 52.12M | 33.05M | |
| 67.67M | 57.88M | 36.27M | 52.12M | 33.05M | |
| -440.99M | -534.26M | -515.29M | -458.16M | -267.85M | |
| -412.69M | -519.02M | -481.19M | -474.19M | -267.89M | |
| -3.81 | -5.25 | -5.42 | -6.16 | -3.78 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 155.46M | 189.18M | 226.75M | 523.51M | 123.41M | |
| 842.13M | 1.19B | 1.30B | 1.52B | 1.29B | |
| 170.73M | 319.06M | 250.81M | 284.53M | 254.22M | |
| 93.33M | 210.20M | 115.35M | 130.70M | 74.02M | |
| 671.39M | 871.96M | 1.05B | 1.24B | 1.04B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -394.74M | -348.88M | -394.09M | -333.29M | -225.03M | |
| 228.03M | 125.57M | -31.35M | 160.31M | -550.78M | |
| 131.49M | 185.75M | 130.32M | 582.96M | 736.69M | |
| -1.13M | -5.78M | -13.98M | -13.41M | -12.76M | |
| -35.22M | -37.57M | -295.11M | 409.98M | -39.12M |